| Ytd | -22.57% | |
| 1y | 13.31% |
| Open | 35.89 | Prev Close | 35.85 | Low | 35.58 | High | 36.51 | Mkt Cap | 1.16B |
| Vol | 12.23K | Avg Vol | 440.41K | EPS | 7.73 | P/E | 4.64 | Forward P/E | 4.86 |
| Beta | 0.73 | Short Ratio | 11.92 | Inst. Own | 128.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 34.71 | 200-d Avg | 39.24 | 1yr Est | 53.60 |
COLL News
Bessemer Group Inc. grew its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ: COLL) by 48.
BOSTON--(BUSINESS WIRE)--DivcoWest, a DivCore Capital company and national commercial real estate in
STOUGHTON, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) a
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech
BBCP, KUBTY, ADM, COLL and W have been added to the Zacks Rank #1 (Strong Buy) List on July 6, 2026.
COLL gains momentum as strong Jornay PM growth and the Azstarys acquisition boosted 2026 guidance, s
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
STOUGHTON, Mass. , June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) t
STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) tod
- Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegi
Collegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call Transcript
The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed
Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.76 per share, beating the Zac
– Generated Quarterly Net Revenues of $193.5 Million, Up 9% Year-over-Year – – Generated JORNAY PM
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for
STOUGHTON, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) t
Collegium Pharmaceutical (NASDAQ: COLL) outlined its 2026 outlook and discussed its planned acquisit
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
On Wednesday, 807 companies reached new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Wednesday